Not investing in technology right now means missing one of the greatest bull markets of all time.
Over the last 10 years, the tech-centric Nasdaq Composite Index has beaten the broader market by more than double.
That outperformance will continue. The American economy now runs on high tech – from chips to cloud computing to biotech to Bluetooth and Wi-Fi, these advanced systems form the backbone of our nation's growth.
And with the Nasdaq off 6% over the last three months, now is the perfect time to get invested and position yourself for maximum tech-sector gains.
I'm about to show you the best stocks to do that with. Each of these stocks is set to crush the broader market over the next decade, and they're bargains right now. Together, they're like a license to print money…
Tech Bargain No. 1: Qualcomm Inc. (Nasdaq: QCOM)
Wall Street has yet to price a big move for Qualcomm Inc. (Nasdaq: QCOM) – the world's largest mobile chip firm – and its $2.4 billion buyout bid of CSR, which is itself a pioneer in Bluetooth and wireless connectivity systems.
CSR ranks as a leader in automotive "infotainment systems," telematics, and technology for the Internet of Everything (IoE). This last market is a potential goldmine for Qualcomm.
The International Data Corporation expects the IoE market, with its billions of interconnected devices, to grow from a value of $1.9 trillion in 2013 to $7.1 trillion by 2020.
Perhaps the best thing about a stock like Qualcomm is that it's a high-margin play on the company's massive patent portfolio. Its patents form the foundation for most of the world's mobile communications.
With an $85 billion market cap, the stock trades at $54.30. It has 30% operating margins and trades at just 11.5 times forward earnings, a 42% discount from the Nasdaq 100.
Tech Bargain No. 2: Apple Inc. (Nasdaq: AAPL)
Apple Inc. (Nasdaq: AAPL) is off its recent highs because Wall Street is worried about Apple's iPhone sales in China. This despite the fact that the iconic smartphone had a 75% sales increase there in the June quarter.
But Wall Street is forgetting just how much the company has going on these days. The new Apple Watch is selling at about 10 million units a year, and the firm just released the iPhone 6s update to rave reviews.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.